Biofarm Bucure (BIO.RO) stock: key figures, P/E, revenue and dividend
Health Care · Romania · ISIN ROBIOFACNOR9
Biofarm Bucure financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 286.77 m RON | 319.33 m RON |
| Gross profit | 241.86 m RON | 272.89 m RON |
| Operating income | 78.27 m RON | 106.93 m RON |
| EBIT | 84.53 m RON | 114.99 m RON |
| Net income | 74.40 m RON | 100.63 m RON |
| Diluted EPS – continuing operations | 0.08 RON | 0.10 RON |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Biofarm Bucure
Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works.
More stocks
- Weaver Fintech Ltd (WVR.JO)
- Hefei Jingsong Intelligent Technology Co. Ltd. A (688251.SS)
- Alto Ingredients, Inc. (ALTO)
- SES AI Corp (SES)
- Harbin VITI Electronics Corp (603023.SS)
- MAUI LAND & PINEAPPLE CO INC (MLP)
- Auk Corp (017900.KS)
- XinJiang Beiken Energy Engineering Stock Co Ltd (002828.SZ)
- Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168.SS)
- Apollo Commercial Real Estate Finance, Inc. (ARI)
- Diana Shipping Inc. (DSX)
- Shanghai Sanmao Enterprise Group Co Ltd B (900922.SS)
Not investment advice. All data without warranty, price as of 24.08.2026. Details in the risk notice.